Andrew Spencer, based in United States, is currently a SVP, Preclinical Research and Development at Spyre Therapeutics, bringing experience from previous roles at AbCellera, Empirico Inc., Sling Therapeutics and MILLENDO THERAPEUTICS. Andrew Spencer holds a 1989 - 1993 BS in Chemistry @ Hope College. With a robust skill set that includes Biotechnology, Drug Discovery, Drug Development, Alliance Management, Management Team Experience and more, Andrew Spencer contributes valuable insights to the industry. Andrew Spencer has 2 emails and 1 mobile phone number on RocketReach.